Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2012
05/03/2012US20120108498 Structural and mechanistic basis for novel compound biosynthesis using the 4-electron hexose oxidase
05/03/2012US20120108497 Compositions for conferring tolerance to viral disease in social insects, and the use thereof
05/03/2012US20120108496 Short-chain peptides as parathyroid hormone (pth) receptor agonist
05/03/2012US20120108493 Polypeptide Fragments Comprising Endonuclease Activity and Their Use
05/03/2012US20120108492 Ligand-specific non-antibody compounds that inhibit cr2 activation and methods of use thereof
05/03/2012US20120108422 Antifungal 1,2,4-triazolyl Derivatives
05/03/2012US20120107897 Double-stranded oligonucleotides
05/03/2012US20120107775 Methods of Using Botanical-Based Compositions to Treat Microbial Dental Disease
05/03/2012US20120107429 Composition For The Prevention And Treatment Of Influenza Virus Infection And Composition For Suppressing Neuraminidase Activity Comprising Turmeric Extract
05/03/2012US20120107424 Anti dengue activity of cissampelos pareira extracts
05/03/2012US20120107415 Combined disinfection and decontamination agent having increased effectiveness
05/03/2012US20120107414 Pharmaceutical formulations and methods for treating respiratory tract infections
05/03/2012US20120107400 Sustained release composition of theraputic agent
05/03/2012US20120107390 Feline infectious peritonitis vaccine
05/03/2012US20120107382 Articles incorporating absorbent polymer and ceragenin compound
05/03/2012US20120107375 Antimicrobial material
05/03/2012US20120107365 Films and particles
05/03/2012US20120107363 Immunogen against campylobacter infection
05/03/2012US20120107360 Gamma-glutamyl transpeptidase attenuated francisella
05/03/2012US20120107359 Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
05/03/2012US20120107358 Subgenomic replicons of the flavivirus dengue
05/03/2012US20120107357 Novel divergent picornavirus: cosavirus
05/03/2012US20120107356 Composition useful as rotavirus vaccine and a method therefor
05/03/2012US20120107354 Viral vaccine and process for preparing the same
05/03/2012US20120107352 Lipopolysaccharide of ochrobactrum intermedium and their use as immunostimulant of mammalians
05/03/2012US20120107350 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof
05/03/2012US20120107349 Multivalent nanoemulsion vaccines
05/03/2012US20120107347 Combination immunotherapy compositions against cancer and methods
05/03/2012US20120107346 Combination vaccines with low does of hib conjugate
05/03/2012US20120107345 Manufacture of vaccines that contain both hepatitis b virus surface antigens and surfactant
05/03/2012US20120107343 Production of recombinant proteins in ciliates and uses thereof
05/03/2012US20120107341 Methods for producing an immune response to tuberculosis
05/03/2012US20120107340 Compositions for immunising against staphylococcus aureus
05/03/2012US20120107339 Chimeric Factor H Binding Proteins (fHBP) Containing a Heterologous B Domain and Methods of Use
05/03/2012US20120107338 Identification of a novel retrovirus in patients with benign prostatic hyperplasia
05/03/2012US20120107336 Modified defensins and their use
05/03/2012US20120107331 Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
05/03/2012US20120107327 Immunogenic compositions of staphylococcus aureus antigens
05/03/2012US20120107326 Neutralizing antibodies to influenza viruses
05/03/2012US20120107322 Immunogenic and therapeutic compositions for streptococcus pyogenes
05/03/2012US20120107319 Pharmaceutical compositions comprising antibodies binding to the intracellular domain of EBV (Epstein-Barr virus) latent membrane protein-1 (LMP1)
05/03/2012US20120107317 Use of cytoplasmic c-myc for regulating immune responses
05/03/2012US20120107316 Protective anti-glucan antibodies with preference for beta-1,3-glucans
05/03/2012US20120107298 Use of LCAT for Treating Anemia and Red Blood Cell Dysfunction
05/03/2012US20120107291 Bifidobacteria for treating diabetes and related conditions
05/03/2012US20120107290 Non-replicating micro-organisms and their immune boosting effect
05/03/2012US20120107289 Lactic Bacteria and Their Use in the Prevention of Diarrhea
05/03/2012US20120107288 Compositions and methods for inhibiting pathogenic growth
05/03/2012US20120107279 Prevention and treatment of rotavirus diarrhoea
05/03/2012US20120107278 Abbreviated hcv therapy for hcv infected patients with il28b c/c genotype
05/03/2012US20120107276 Anti-Arenaviral Compounds
05/03/2012US20120107275 Fused heterocyclic derivatives and methods of use
05/03/2012US20120107274 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
05/03/2012US20120107273 New piperazine compound and use thereof as a hcv polymerase inhibitor
05/03/2012US20120107272 Synthetic methods and derivatives of triphosphate oligonucleotides
05/03/2012US20120107271 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
05/03/2012US20120107269 Thiophene derivatives
05/03/2012US20120107268 Lymph node-targeting nanoparticles
05/03/2012US20120107254 Long Wear Topical Composition
05/03/2012US20120107252 Method for forming cyclodextrin polymer and lipophilic compound emulsions, resulting emulsions, and compositions including said emulsions
05/03/2012US20120107247 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and their Use as Diagnostic Reagents and Vaccines
05/03/2012US20120107243 Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier
05/03/2012DE102010049877A1 7-((1,2,3)Triazol-4-yl)-pyrrolo(2,3) pyrazinderivate 7 - ((1,2,3) triazol-4-yl) pyrrolo (2,3) pyrazine
05/03/2012CA2853613A1 Hbv treatment
05/03/2012CA2816052A1 Liquid formulations of long acting interferon alpha conjugate
05/03/2012CA2815888A1 Clostridium difficile-specific antibodies and uses thereof
05/03/2012CA2815537A1 Inhibitors of hepatitis c virus
05/03/2012CA2814908A1 Antibodies for the treatment of hiv
05/03/2012CA2814703A1 Hiv integrase inhibitors
05/03/2012CA2814436A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders
05/02/2012EP2447369A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447368A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447367A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447278A1 Novel immunogenic proteins of Leptospira
05/02/2012EP2447253A1 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
05/02/2012EP2446899A2 Adjuvant composition comprising (poly-gamma-glutamate)-chitosan nanoparticles
05/02/2012EP2446898A1 Use of growth hormone to enhance the immune response in immunosuppressed patients
05/02/2012EP2446897A1 Anti-KIR combination treatments and methods
05/02/2012EP2445937A1 Bispecific antibodies that bind to complement proteins
05/02/2012EP2445928A1 Chimeric influenza virus-like particles comprising hemagglutinin
05/02/2012EP2445927A1 Lipidated tumor- associated antigens and immunotherapeutic compositions
05/02/2012EP2445588A2 Topical formulation containing a tetracycline and a method of treating skin infections using the same
05/02/2012EP2445495A1 Composition for treatment of tuberculosis
05/02/2012EP2445349A1 Compounds and methods for treating influenza
05/02/2012EP2124993B1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use
05/02/2012EP2081926B1 Preparation and purification of mupirocin calcium
05/02/2012EP1924597B1 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants
05/02/2012EP1789042B1 1-alkoxy 1h-imidazo ring systems and methods
05/02/2012EP1597280B1 Monoclonal antibody production by ebv transformation of b cells
05/02/2012EP1549246B1 Antibiotic micropheres for treatment of infections and osteomyelitis
05/02/2012EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
05/02/2012EP1507796B1 Cross-linked glycopeptide-cephalosporin antibiotics
05/02/2012EP1429723B1 Treating effects of excessive reactive oxygen species
05/02/2012EP1256348B1 Remedies for hepatitis c
05/02/2012CN1815234B Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof
05/02/2012CN1404398B Improved DNA vaccines for production-type animals
05/02/2012CN102439155A Auxotrophic, recombinant bcg strain pasteur and use thereof for combating human infections caused by parasites
05/02/2012CN102439153A Compositions for stimulation of mammalian innate immune resistance to pathogens
05/02/2012CN102439134A Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s)
05/02/2012CN102439026A Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin
1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 1798